Lexeo Therapeutics
$4.89
18
+$0.05+1.03% Friday 20:00
Statistics
Day High
4.91
Day Low
4.9
52W High
10.99
52W Low
3.99
Volume
23,958
Avg. Volume
-
Mkt Cap
401.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
14DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.99
-0.74
-0.5
-0.25
Expected EPS
-0.328889
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-99.96MNet Income
Analyst Ratings
9.00Average Price Target
The highest estimate is 9.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LXEO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
Show more...
CEO
R. Nolan Townsend
Employees
59
Country
United States
ISIN
US52886X1072
Listings
0 Comments
Share your thoughts
FAQ
What is Lexeo Therapeutics stock price today?▼
The current price of LXEO is $4.89 USD — it has increased by +1.03% in the past 24 hours. Watch Lexeo Therapeutics stock price performance more closely on the chart.
What is Lexeo Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lexeo Therapeutics stocks are traded under the ticker LXEO.
Is Lexeo Therapeutics stock price growing?▼
LXEO stock has risen by +0.62% compared to the previous week, the month change is a +7.47% rise, over the last year Lexeo Therapeutics has showed a -2.59% decrease.
What is Lexeo Therapeutics market cap?▼
Today Lexeo Therapeutics has the market capitalization of 401.21M
When is the next Lexeo Therapeutics earnings date?▼
Lexeo Therapeutics is going to release the next earnings report on December 14, 2026.
What were Lexeo Therapeutics earnings last quarter?▼
LXEO earnings for the last quarter are -0.3 USD per share, whereas the estimation was -0.29 USD resulting in a -5.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lexeo Therapeutics revenue for the last year?▼
Lexeo Therapeutics revenue for the last year amounts to 0 USD.
What is Lexeo Therapeutics net income for the last year?▼
LXEO net income for the last year is -99.96M USD.
How many employees does Lexeo Therapeutics have?▼
As of September 06, 2026, the company has 59 employees.
In which sector is Lexeo Therapeutics located?▼
Lexeo Therapeutics operates in the Health & Wellness sector.
When did Lexeo Therapeutics complete a stock split?▼
Lexeo Therapeutics has not had any recent stock splits.
Where is Lexeo Therapeutics headquartered?▼
Lexeo Therapeutics is headquartered in NEW YORK, United States.